A disposition kinetic study of tramadol in rat perfused liver

Biopharmaceutics and Drug Disposition

Volumn 29, Issue 4, 2008, Pages 231-235

  Rouini, Mohammad Reza ^a   Ghazi Khansari, Mahmoud ^b   Ardakani, Yalda H ^a   Dasian, Zahra ^a   Lavasani, Hoda ^a  

^a Tehran University of Medical Sciences   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Liver perfusion; Pharmacokinetic; Rat; Tramadol

Indexed keywords

ANALGESIC AGENT; DRUG METABOLITE; N DESMETHYLTRAMADOL; N,O DESMETHYLTRAMADOL; O NORTRAMADOL; TRAMADOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATED LIVER; LIVER CLEARANCE; LIVER PERFUSION; MALE; NONHUMAN; RAT;

ANALGESICS; ANIMALS; LIVER; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRAMADOL;

EID: 44949228453     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.606     Document Type: Article

References (11)

1. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275-285.
2. Dayer P, Collart L, Desmeules J. The pharmacology of tramadol. Drugs 1994; 47(Suppl. 1): 3-7.
3. Lewis KS, Han NH. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm 1997; 54: 643-652.
4. Lintz W, Barth H, Becker R, Frankus E, Schmidt-Bothelt E. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Arzneimittelforschung 1998; 48: 436-445.
5. Budd K, Langford R. Tramadol revisited. Br J Anaesth 1999; 82: 493-495.
6. Lintz W, Erlacin S, Frankus E. Biotransformation of tramadol in man and animal [in German]. Arneimittelforschung 1981; 31: 1932-1943.
7. Wu WN, McKown LA, Liao S. Metabolism of the analgesic drug Ultram® (tramadol hydrochloride) in humans: API-MS and MS/MS characterization of metabolites. Xenobiotica 2002; 32: 411-425.
8. Subrahmanyam V, Renwick AB, Walters DG, et al. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab Dispos 2001; 29: 1146-1155.
9. Cheung K, Hickman PE, Potter JM, et al. An optimized model for rat liver perfusion studies. J Surg Res 1996; 66: 81-89.
10. Ardakani YH, Rouini MR. Improved liquid chromatographic method for the simultaneous determination of tramadol and its three main metabolites in human plasma, urine and saliva. J Pharm Biomed Anal 2007; 44: 1168-1173.
11. Raffa RB, Nayak RK, Liao S, et al. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Rev Contemp Pharmacother 1995; 6: 485-497.